Sage Therapeutics | 8-K: Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics | DEFA14A: Others
Sage Therapeutics | DEF 14A: Definitive information statements
Sage Therapeutics | 8-K: Current report
Sage Therapeutics | 8-K: Current report
Sage Therapeutics | 8-K: Current report
Sage Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Sage Therapeutics | 8-K: Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics | 8-K: Current report
Sage Therapeutics | 8-K: Current report
Sage Therapeutics | 8-K: Current report
Sage Therapeutics | DEFA14A: Others
Sage Therapeutics | DEF 14A: Definitive information statements
Sage Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Sage Therapeutics | 8-K: Current report
Sage Therapeutics | 8-K: Sage Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics | 8-K: Current report
Sage Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Sage Therapeutics | 8-K: Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics | 8-K: Current report
No Data